Vivos Therapeutics, Inc Claimed Company

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is an innovative medical technology company focused on the development and commercialization of screening and treatment for obstructive sleep apnea (OSA). Vivos offers a multidisciplinary treatment protocol that uses nonsurgical, noninvasive, and cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial anomalies and/or mild to moderate OSA. This revolutionary treatment is called the Vivos Method. Combining technologies and protocols that alter the size, shape, and position of the tissues of the upper airway, the Vivos Method opens airway space and can significantly reduce or even eliminate the symptoms and conditions associated with mild to moderate OSA. read more

EMPLOYEE PARTICIPANTS: 4

TOTAL RATINGS: 30

CEO: R. Kirk Huntsman

HR or Marketing? Claim Your Free Employer Account

R. Kirk Huntsman Vivos Therapeutics, Inc CEO Rating

Employees at Vivos Therapeutics, Inc gave their CEO, R. Kirk Huntsman, an average score of 85/100.

Get insights into the CEO Rating Score of Vivos Therapeutics, Inc. See CEO Rating Score by Department, Gender, Ethnicity and more.

Last updated months ago.

Where This Score Ranks Vivos Therapeutics, Inc's CEO Rating

?
Not enough ratings to compare against similar size companies on Comparably.
?
Not enough ratings to compare against all size companies in Denver.
?
Not enough ratings to compare against competitors.

Not Enough Ratings to Display

Rate Your Experience

Vivos Therapeutics, Inc CEO R. Kirk Huntsman Bio

R. Kirk Huntsman is a co-founder of our company and has served as our Chief Executive Officer and a director since September 2016. In June 2020, he was elected Chairman of the Board by our board of directors. In 1995, he founded Dental One (now Dental One Partners), which, as President and Chief Executive Officer he grew to become one of the leading DSOs (dental service organizations) in the country, with over 165 practices in 15 states. After a successful sale of Dental One to MSD Capital in 2008 and subsequent merger in 2009 with Dental Care Partners, Mr. Huntsman was appointed in 2010 as Chief Executive Officer of ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. In 2012, he founded Xenith Practices, LLC, a DSO focused on rolling up larger independent general dental offices, which were sold in 2015. From January 2014 to September 2015, Mr. Huntsman founded and served as the Chief Executive Officer of Ortho Ventures, LLC, a US distributor of certain pediatric oral appliances with applications for pediatric sleep disordered breathing. Since November 2015, he has served as the Chief Executive Officer of First Vivos, Inc., which is now our wholly owned subsidiary. He was also a founding member of the Dental Group Practice Association (DGPA), now known as the Association of Dental Support Organizations (ADSO). He is the father of Todd Huntsman. He holds a BS degree in finance from Brigham Young University.

Who Ranks Vivos Therapeutics, Inc's CEO Rating the Highest?

Not Enough Ratings To Show Who Ranks CEO Rating the Highest

Anonymously rate my experience at Vivos Therapeutics, Inc

Who Ranks Vivos Therapeutics, Inc's CEO Rating the Lowest?

Not Enough Ratings To Show Who Ranks CEO Rating the Lowest

Anonymously rate my experience at Vivos Therapeutics, Inc